chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I developed Shingles two weeks after receiving my first vaccination; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 63-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EP075333), via an unspecified route of administration, administered in arm left on 31Mar2021 at 13:30 (01:30 PM) (at the age of 63-year-old) as dose 1, single for COVID-19 immunization. Medical history included GERD and known allergies: PCN. The patient concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. Patient was not diagnosed with COVID prior vaccination. Patient had not been COVID tested post vaccination. On 10Apr2021, the patient experienced I developed shingles two weeks after receiving my first vaccination. AE resulted in doctor or other healthcare professional office/clinic visit. Adverse event: I developed Shingles two weeks after receiving my first vaccination and wondering if this is a side effect. Just read an article regarding herpes rash as a side effect. The patient received Antiviral and topical cream as a treatment medication for the event. Outcome of the event was recovering.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Pain of skin, Rash
Clinical narrative: This is a spontaneous report from a contactable consumer. This 28-year-old male consumer (patient) reported.  A 28-year-old male patient received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered in right arm on 09Apr2021 12:30 PM (at the age of 28-year-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 18Apr2021 12:00 PM, after the vaccination, the patient experienced Shingles and skin tenderness began. On 22Apr2021 patient experienced Rash. Patient received Valacyclovir for shingles as treatment option. Patient took no other vaccines in four weeks and no other medications in two weeks. The patient was not diagnosed with covid prior vaccination and patient was tested covid post vaccination. No known allergies found. The outcome of the events was recovering at the time of this report.  No follow-up attempts possible. No further information expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Herpes zoster, Neuralgia, Pain
Clinical narrative: Shingle outbreak 5 days after first shot in area of left side of neck, ear and back of head; Blister and extreme pain; Blister and extreme pain; Nerve pain; This is a spontaneous report received from a contactable consumer or other non-health care professional (patient). A 52-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6207), via an unspecified route of administration, administered in Arm Right on 17Mar2021 18:00 as dose 1, single and a second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0161), via an unspecified route of administration, administered in Arm Right on 13Apr2021 18:00 (at the age of 52-years-old) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were nor reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Patient had no health issues prior to vaccine. Patient received vaccine Facility in Hospital. On 22Mar2021 03:00, shingle outbreak 5 days after first shot in area of left side of neck, ear and back of head. Blister and extreme pain that required doctor care. Completed 10 days of prescribed medicine and was getting better. 2nd outbreak occurred after getting 2nd Covid vaccine. Same area, but less blistering. Still extreme nerve pain. Treatment was received for the events as Valacyclovir for 10 days. Patient visited Doctor or other healthcare professional office/clinic visit. The outcome of the events was reported as recovering.   Follow-Up (15Sep2021): Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles/Shingle site located on septum of nose; This is a spontaneous report from a contactable consumer (patient). A 47-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0164) via an unspecified route of administration, administered in Arm Right on 13Apr2021 17:30 (at the age of 47 years old) as dose 2, single for COVID-19 immunisation at Public Health Clinic/Veterans Administration facility. Medical history reported as none. Concomitant medication within two weeks included atorvastatin (ATORVASTATIN), eicosapentaenoic acid ethyl ester (VASCEPA), levothyroxine sodium (LEVOTHYROXIN), all taken for an unspecified indication, start and stop date were not reported. Patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: ER8733) via an unspecified route of administration, administered in Arm Right on 23Mar2021 17:30 (at the age of 47 years old) as single for COVID-19 immunisation. Patient did not received other vaccine in four weeks of COVID vaccine. Patient did not have COVID prior to vaccination. The patient experienced shingles/shingle site located on septum of nose on 19Apr2021 08:00. Event reported as, Shingles diagnosed by PhD medical professional. Shingle site located on septum of nose. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Treatment included anti-viral prescribed and ophthalmolog appointment. Patient did not tested for COVID post vaccination. Outcome of the event was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Groin pain, Herpes zoster, Pain in extremity, Rash
Clinical narrative: Shingles; Pain in my right knee; I had pain in my right leg moving around between thigh groin and knee; I had pain in my right leg moving around between thigh groin and knee; As I received my vaccine I immediately got pain in my right knee. Found it strange. Each day following for 4 days I had pain in my right leg moving around between thigh groin and knee. Day 5 rash brok; As I received my vaccine I immediately got pain in my right knee. Found it strange. Each day following for 4 days I had pain in my right leg moving around between thigh groin and knee. Day 5 rash brok; This is a spontaneous report from a contactable consumer (Patient). A 60-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTEHC COVID-19 VACCINE, Batch/Lot number was not reported), Solution for injection via an unspecified route of administration, administered in Arm Left on 16Apr2021 17:45 (at the age of 60-year-old) as single dose for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included tetanus vaccine (TETANUS VACCINE) on 01Apr2021, metformin hydrochloride, sitagliptin phosphate monohydrate (JANUMET) and atorvastatin calcium (ATORVASTATIN CALCIUM). Patient had no known allergies. Patient was not diagnosed with COVID-19 prior vaccination. On 21Apr2021, the patient experienced shingles, pain in my right knee, had pain in my right leg moving around between thigh groin and knee, as he received vaccine immediately got pain in right knee. found it strange. each day following for 4 days had pain in right leg moving around between thigh groin and knee. day 5 rash brok. It was reported that, as he received his vaccine he immediately got pain in his right knee. Found it strange. Each day following for 4 days he had pain in his right leg moving around between thigh groin and knee. Day 5 rash broke out and was determined to be Shingles. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 20Apr2021. Therapeutic measures were taken as a result of adverse events, antiviral drug and pain meds. Event resulted into emergency Room and physician office visit. The outcome of events was recovering.   The lot number for [BNT162B2], was not provided and will be requested during follow up.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Herpes zoster
Clinical narrative: left temporal headache; Shingles; This is a spontaneous report from a contactable consumer (patient). A 57-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number: ER8729) via an unspecified route of administration in arm left on 21Apr2021 12:45 as dose 2, single (age at vaccination: 57 years) for COVID-19 immunisation. Medical history included multifocal GBM responsive, chicken pox as a child to treatment, both from an unknown date and unknown if ongoing. Concomitant medications included simvastatin (AVASTIN [SIMVASTATIN]) infusion; temozolomide (TEMODAR) oral, both taken for an unspecified indication, start and stop date were not reported. Historical vaccine includes bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number: EP7534) via an unspecified route of administration in arm right on 23Mar2021 01:00 as dose 1, single for COVID-19 immunisation. No other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No covid prior vaccination and did not tested COVID post vaccination. No known allergies. On 22Apr2021 at 12:00, the patient experienced left temporal headache reduced by Tylenol for two days, followed by small outbreak of shingles on left front scalp. No treatment received and no history of shingles. The clinical outcome of the event left temporal headache was resolving and the event shingles was not resolved.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: her husband cut his hand and was in the emergency room and had stitches; Arm hurts a little bit; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of an unspecified age received bnt162b2 (BNT162B2) formulation solution for injection, dose 2 (Lot number and expiry date was not reported) via an unspecified route of administration on 20Apr2021 as a single for covid-19 immunisation. Medical history included Parkinson's disease from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Reported stated that her husband received his second dose of the Covid 19 Vaccine yesterday. Yesterday afternoon he was walking down the street with a glass bottle in his hand. He fell and the bottle broke and cut his hand. Reporter stated her husband has Parkinson's Disease. Reporter took her husband to the doctor after his fall and the doctor put him on Antibiotics and wanted to give him a Tetanus Vaccine. She is calling to see how soon after the Covid 19 Vaccine he will be able to get this Tetanus Vaccine; he has not received it yet. Reporter was declining to complete report. She stated she's not reporting anything to do with the shot. Says her husband has Parkinson's Disease and he falls all of the time. Stated the fall he had was not related to his vaccination. She said the only thing he had related to the vaccine was his arm hurts a little bit. Reporter said when she went to pick up her husband's antibiotics the pharmacist told her that he would have to wait until two weeks after his Covid 19 Vaccine to get any other vaccinations. including the Tetanus Vaccine. Reporter stated she just wants to be transferred so they can tell her if 2 weeks is the correct amount of time. Also asks if the second dose of the vaccine has to be right at 3 weeks from the first dose. Outcome of the events was unknown   No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstrual disorder
Clinical narrative: I started menstruating again (note, this is only 2 weeks after my previous period)/lasted 7 days - nearly twice my usual period length; It was more than twice my usual flow; This is a spontaneous report from a non-contactable consumer or other non healthcare professional. A 43 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 07Apr2021 13:30 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included food allergy to mango from an unknown date and unknown if ongoing. There were no concomitant medications. The patient experienced normal menstruation on 29Mar. It lasted its usual 3-4 days. A week later, on 07Apr, she had the first dose of the Pfizer vaccine. A week after that, on 13Apr, she started menstruating again, this is only 2 weeks after her previous period. This menstruation was extremely unusual. It started mid-cycle, when she normally is very regular. It was not accompanied by any of the usual PMS symptoms, like sore breasts or fatigue. It was more than twice her usual flow and lasted 7 days which is  nearly twice her usual period length causing menstrual disorder and heavy menstrual bleeding on 13Apr2021 with outcome of unknown. No follow-up attempts are possible; information about Lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: Vesicular rash noted on back 22 days post vaccine Diagnosed as shingles; Vesicular rash noted on back 22 days post vaccine Diagnosed as shingles; This is a spontaneous report from a contactable other healthcare professional. A 39 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 28Mar2021 10:45 (Batch/Lot Number: EF8732) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, drug hypersensitivity to Penicillin, sulpha from an unknown date and unknown if ongoing. There were no concomitant medications. The patient experienced vesicular rash noted on back 22 days post vaccine diagnosed as shingles or Herpes Zoster on 19Apr2021 20:00 with outcome of recovering. The patient had to visit physician office. Therapeutic measures were taken as a result of the events with Valtrex  Follow-Up (15Sep2021): Follow-up attempts are completed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (Patient). A 69-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6203), dose 1 via an unspecified route of administration in left arm on 06Mar2021 at 13:30 (at the age of 69-year-old) as dose 1, single for COVID-19 immunisation at other facility. Medical history included Sulfa (drug allergy) from an unknown date and unknown if ongoing, COVID-19 from an unknown date and unknown if ongoing. Concomitant medications included atenolol, dexlansoprazole (DEXILANT), levothyroxine sodium (SYNTHROID), pitavastatin calcium (LIVALO), colecalciferol (VITAMIN D 3); all from unknown dates to unknown dates for unknown indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced shingles on 14Mar2021. The adverse event was resulted in doctor or other health care professional office/clinic visit. Anti-viral and topical cream was given as a treatment for event. The outcome of the event was reported as resolved on an unknown date.  Follow-up attempts are completed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Coagulopathy, Fatigue, Heavy menstrual bleeding
Clinical narrative: Continuing Fatigue two weeks after second dose.; Extreme heavy menstrual period with clotting; Extreme heavy menstrual period with clotting; This is a spontaneous report from a contactable consumer. A 29-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: Unknown) via an unspecified route of administration, administered in Arm Left on 12Apr2021 at 17:30 as DOSE 2, SINGLE (at the age of 29-year-old) for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received dose 1 on 22Mar2021 at 05:30 PM (Batch/Lot number: Unknown) for covid-19 immunisation. On 21Apr2021 at 04:30 PM, patient continued fatigue two weeks after second dose. Extreme heavy menstrual period with clotting that did not occur with prior periods. AE resulted in Emergency room/department or urgent care. It was unknown if the patient received the treatment or not. The outcome of the events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pain
Clinical narrative: the sores were so bad; shingles; This is a spontaneous report from a contactable Consumer or other non-HCP (patient). A 66-year-old Elderly female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: E19266), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 (at the age of 66-year-old), as DOSE 2, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included sarcoidosis from an unknown date and unknown if ongoing. The patient had no covid prior vaccination. The patient had no Known allergies. Concomitant medication(s) included Prednisone; Azathioprine; Gabapentine and 'Hydoxychor''all taken for an unspecified indication, start and stop date were not reported. The patient previously received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EL9261), via an unspecified route of administration, administered in Left arm on 30Jan2021 (at the age of 66-year-old), as single for covid-19 immunisation and had sores on her left back hip. The patient had no other vaccine in four weeks. The patient had not been covid tested post vaccination. On an unspecified date in 2021, after the second dose, the patient experienced sores that were so bad and shingles. It was reported that the shingles was diagnosed after the second does when the sores were so bad, she went to her internist who referred her to dermatologist and was diagnosed with Shingles. The AE resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received to treat the events. The patient outcome of the events was resolved on an unspecified date in 2021.  No follow-up attempts are possible, information. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngitis streptococcal, Pityriasis rosea, Scar, Streptococcus test
Clinical narrative: Throat infection (Strep Throat Positive); scar; Pityriasis Rosea; This is a spontaneous report from a contactable consumer (patient herself). A 23-years-old non-pregnant female patient received bnt162b2 (BNT162B2, formulation: solution for injection, Lot Number: EW0150, Expiry date: Unknown) via an unspecified route of administration in Arm Left on 07Apr2021 09:15 as dose 1, single (at the age of 23 years) for COVID-19 immunization. The patient medical history was not reported and there were no concomitant medications. There were no known allergies. Prior to vaccination, patient did not have COVID-19. Covid-19 was not tested post vaccination. On 14Apr2021, the patient first noticed a scar appearing on Chest, Pityriasis Rosea and on 21Apr2021, experienced throat infection. The scar started growing over a couple of days into a circular Herald Patch appearance. Along with the growth of that one patch, smaller scars started appearing on left side of lower back. Since then, the smaller ones have grown into an almond shape larger appearance. Similar smaller ones have been noticed on underarm and appears as though more are starting to appear on stomach. Patient went to Clinic for consolation and doctor suspects it could be a reaction to vaccination and that it looks like a case of Pityriasis Rosea. No irritation or itching was reported. Purely visible with no symptoms of irritation. Therapeutic measures were taken for throat infection (Strep Throat Positive) and have been on Ibuprofen and Antibiotics (Penicillin) and therapeutic measures were not taken for other events. The outcome of the events was reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling cold, Hypoaesthesia, Nerve injury, Paraesthesia
Clinical narrative: my left arm went numb. My pinky and ring finger was numb and tingly; my left arm went numb. My pinky and ring finger was numb and tingly; felt cold; I had the sensation from the top of my head down to my foot.; I had pain in my hip; I alerted the doctor on staff and was told the nurse probably hit a nerve.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 36-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:30 (at the age of 36years) (Batch/Lot Number: EP7533) as DOSE 1, SINGLE for Covid-19 immunization at Hospital. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Medical history included mild asthma and Arrowroot (food allergy) from an unknown date and unknown if ongoing. Concomitant medications included ascorbic acid, beta carotene, cupric oxide, manganese sulfate, selenium, tocopheryl acetate, ubidecarenone, zinc oxide (COQ10 [ASCORBIC ACID; BETACAROTENE; CUPRIC OXIDE; MANGANESE SULFATE; SELENIUM; TOCOPHERYL ACETATE; UBIDECARENONE; ZINC OXIDE]); folic acid and omega-3 fatty acids (OMEGA-3 FATTY ACIDS) taken for an unspecified indication, start and stop date were not reported. The patient stated, on 06Apr2021 11:30AM ''Immediately after my first dose my left arm went numb. My pinky and ring finger was numb and tingly and felt cold. I had the sensation from the top of my head down to my foot. I still feel it now through the nerves going to my spine on my left side, my IT band, triceps, wrist arm, head, literally my entire left side. I had pain in my hip as well. 3 weeks later I have the same numbness in my fingers, head, face, back, and leg. I alerted the doctor on staff and was told the nurse probably hit a nerve''. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 16Apr2021. The clinical outcome of the events was not recovered at the time of vaccination.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Sensitisation
Clinical narrative: my left arm went numb. My pinky and ring finger was numb and tingly; my left arm went numb. My pinky and ring finger was numb and tingly; felt cold; I had the sensation from the top of my head down to my foot.; I had pain in my hip; I alerted the doctor on staff and was told the nurse probably hit a nerve.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 36-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:30 (at the age of 36years) (Batch/Lot Number: EP7533) as DOSE 1, SINGLE for Covid-19 immunization at Hospital. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Medical history included mild asthma and Arrowroot (food allergy) from an unknown date and unknown if ongoing. Concomitant medications included ascorbic acid, beta carotene, cupric oxide, manganese sulfate, selenium, tocopheryl acetate, ubidecarenone, zinc oxide (COQ10 [ASCORBIC ACID; BETACAROTENE; CUPRIC OXIDE; MANGANESE SULFATE; SELENIUM; TOCOPHERYL ACETATE; UBIDECARENONE; ZINC OXIDE]); folic acid and omega-3 fatty acids (OMEGA-3 FATTY ACIDS) taken for an unspecified indication, start and stop date were not reported. The patient stated, on 06Apr2021 11:30AM ''Immediately after my first dose my left arm went numb. My pinky and ring finger was numb and tingly and felt cold. I had the sensation from the top of my head down to my foot. I still feel it now through the nerves going to my spine on my left side, my IT band, triceps, wrist arm, head, literally my entire left side. I had pain in my hip as well. 3 weeks later I have the same numbness in my fingers, head, face, back, and leg. I alerted the doctor on staff and was told the nurse probably hit a nerve''. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 16Apr2021. The clinical outcome of the events was not recovered at the time of vaccination.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a non-contactable consumer or other non hcp.   A 38-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No was not reported), via an unspecified route of administration on 16Apr2021 14:00 as dose number unknown, single for covid-19 immunisation (age at vaccination was 38 years). Medical history included drug hypersensitivity from an unknown date and unknown if ongoing (penicillin allergy).     The patient's concomitant medications were not reported.The patient experienced shingles on 17Apr2021 10:00.Therapeutic measures were taken as a result of shingles. Treatment was received. Outcome of the event was recovering.    No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I developed shingles 2 days after getting the 1st dose of Pfizer vaccine.; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 74-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), first dose via an unspecified route of administration, administered in left arm on 13Mar2021 at 13:00 (at the age of 74-year-old) as dose 1, single for COVID-19 immunisation at military base. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing Other medical history: High cholesterol, high BP, hypertension from an unknown date and unknown if ongoing Other medical history: High cholesterol, high BP. No known allergies were reported. The patient's concomitant medications in two weeks of COVID-19 vaccination included blood pressure, cholesterol, multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. It was reported that on 16Mar2021, the patient developed shingles 2 days after getting the 1st dose of Pfizer vaccine. Adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Unspecified medication was given as treatment for the events. The outcome of the event was reported as resolved with lasting effects.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Fatigue, Herpes zoster, Malaise, Neuralgia
Clinical narrative: Shingles; exhausted; pain/ache; general malaise; burning; stinging nerve pain; This is a spontaneous report from a contactable other HCP (patient). A 28-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot number was not reported) via an unspecified route of administration in arm right on 26Mar2021 11:45 as dose 1, single (age at vaccination: 28 years) for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. No other vaccine in four weeks. No COVID prior vaccination and did not tested COVID post vaccination. On 09Apr2021 at 12:30 PM, the patient experienced shingles, symptoms began approx 1 week post dose, exhausted, ache, pain, general malaise. Started with burning, stinging nerve pain inner right thigh also located on right side of scalp. Lesions approx 2 weeks post dose. Started antivirals. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Treatment received was antivirals. The clinical outcome of the events was resolving.  No follow up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Shingles; exhausted; pain/ache; general malaise; burning; stinging nerve pain; This is a spontaneous report from a contactable other HCP (patient). A 28-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot number was not reported) via an unspecified route of administration in arm right on 26Mar2021 11:45 as dose 1, single (age at vaccination: 28 years) for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. No other vaccine in four weeks. No COVID prior vaccination and did not tested COVID post vaccination. On 09Apr2021 at 12:30 PM, the patient experienced shingles, symptoms began approx 1 week post dose, exhausted, ache, pain, general malaise. Started with burning, stinging nerve pain inner right thigh also located on right side of scalp. Lesions approx 2 weeks post dose. Started antivirals. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Treatment received was antivirals. The clinical outcome of the events was resolving.  No follow up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (patient herself) via COVID-19 Adverse Event Self-Reporting Solution (COVAES). A 52 years old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ew0153) via an unspecified route, administered in Right Arm on 08Apr2021 at 13:30 (52-year-old at vaccination) as a Dose 1, Single for COVID-19 immunization. The patient was non-pregnant at time of vaccination. The patient's medical history included known allergies to Penicillin, Sulfa drugs. The patient's concomitant medications were not reported.  The patient previously took septra and experienced allergy. Facility type vaccine was reported as Other. The patient was not diagnosed for Covid prior vaccination. The patient had not received any other vaccine within four weeks prior to vaccination. On 15Apr2021, the patient experienced shingles. Ae resulted in Doctor or other healthcare professional office/clinic visit. The patient was not tested for covid post vaccination. No treatment received for the event. The outcome of the events was Not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Coagulopathy, Epistaxis
Clinical narrative: a severe nosebleed; a severe nosebleed with clotting; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (daughter). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 2 via an un-specified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunization. The patient medical and concomitant medication history were reported. It was mentioned that, just wanted to update about a reaction patient had that was associated with recent vaccination. Patient (my daughter) had a severe nosebleed with clotting after second COVID19 vaccination. The outcome of the events were unknown.  The lot number was not provided. Information on lot number has been requested during follow up.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Herpes zoster, Neck pain, Neuralgia, Pain in extremity
Clinical narrative: Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; This is a spontaneous report from a contactable consumer or other non hcp. A 56-years-old male patient received bnt162b2 (BNT162B2), dose 2 (Lot number and expiry date was not reported) via an unspecified route of administration at arm left on 26Feb2021 07:00 (at the age of 56-years-old) as a single for covid-19 immunisation. Medical history included hypergammaglobulinemia benign monoclonal, food allergy from an unknown date and unknown if ongoing. Concomitant medication(s) included finasteride taken for an unspecified indication, start and stop date were not reported. Historical Vaccine BNT162B2 dose 1 (lot number and expiry date was unknown) via unspecified route of administration aa a single dose for COVID-19 immunisation. Severe Pain started in injection arm went up neck then into shoulder  in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulder in 7th week - started 05Mar2021 19:00 pain. Still in nerve pain in left arm and shoulder. Therapeutic measures were taken as a result of severe pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which doctor said was shingles - still in nerve pain in left arm and shoulder. Outcome of the events was not recovered.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; This is a spontaneous report from a contactable consumer or other non hcp. A 56-years-old male patient received bnt162b2 (BNT162B2), dose 2 (Lot number and expiry date was not reported) via an unspecified route of administration at arm left on 26Feb2021 07:00 (at the age of 56-years-old) as a single for covid-19 immunisation. Medical history included hypergammaglobulinemia benign monoclonal, food allergy from an unknown date and unknown if ongoing. Concomitant medication(s) included finasteride taken for an unspecified indication, start and stop date were not reported. Historical Vaccine BNT162B2 dose 1 (lot number and expiry date was unknown) via unspecified route of administration aa a single dose for COVID-19 immunisation. Severe Pain started in injection arm went up neck then into shoulder  in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulder in 7th week - started 05Mar2021 19:00 pain. Still in nerve pain in left arm and shoulder. Therapeutic measures were taken as a result of severe pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which doctor said was shingles - still in nerve pain in left arm and shoulder. Outcome of the events was not recovered.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Investigation
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 61-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0170), via an unspecified route of administration (at the age of 61-years), administered in arm left on 20Apr2021 at 14:30 as dose 2, single for COVID-19 immunization. Medical history included none from an unknown date and unknown if ongoing. There were no concomitant medications. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER8733), via an unspecified route of administration, administered in arm left on 30Mar2021 at 14:45 as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccine in four weeks. Patient does not have covid prior vaccination and has not been tested for covid post vaccination. The patient had no known allergies. The vaccine facility type was reported as other. No other medications were received within two weeks. On 23Apr2021, the patient experienced shingles. It was reported that symptoms were started 2 or 3 days after the vaccine on 20Apr21 and prescribed valacyclovir on 27Apr2021. The treatment was received for the adverse event with valacyclovir 1gm 3 for 7 days. The adverse events resulted in physician office visit. The patient underwent lab tests and procedures which included investigation: shingles on 27Apr2021. The clinical outcome of the event was reported as recovering.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding
Clinical narrative: Excessively heavy period about 3 weeks after second shot; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 23-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 06Apr2021 14:00 as DOSE 2, SINGLE for covid-19 immunization (23 year when vaccinated) at public health clinic. Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 16Mar2021 14:00 as DOSE 1, SINGLE for covid-19 immunization (23 year when vaccinated) and experienced irregular periods and heavy menstrual bleeding. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient medical history and concomitant medications were not reported. On an unknown date in Apr2021, the patient reported that since having both the vaccination the patient has been having excessively heavy period about 3 weeks after second shot with huge clots, and she bleeds so much that she soaked through tampon and pad in an hour. The patient had to visit the doctor in the emergency room. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any treatment for the events. The outcome of the event was reported as unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I got shingles; This is a spontaneous report from a contactable consumer or other non hcp (patient reported for herself). A 81-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: en9581), via an unspecified route of administration, administered in arm right on 09Feb2021 at 10:00 AM (at the age of 80-year-old) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: 9037765622), via an unspecified route of administration, administered in arm right on 19Jan2021 (at the age of 81-year-old) as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccine in four weeks. The patient did not receive any other medications in two weeks. On 23Feb2021, the patient experienced I got shingles. AE resulted in emergency room/department or urgent care. The patient received Gabapentin as a treatment medication for the event. Outcome of the event was recovering.  Follow-up (15Sep2021): Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles - Herpes Zoster; This is a spontaneous report received from a contactable consumer or other non hcp. A 39-years-old female patient received 1st dose of bnt162b2 (COMIRNATY,Batch/Lot Number: EL9266), via an unspecified route of administration on 12Feb2021 09:00,at the age of 39 years old, as Dose 1,single for covid-19 immunization.Medical history included parkinson's disease, thyroiditis, cholecystectomy from an unknown date and unknown if ongoing. Concomitant medications included cetirizine hydrochloride (ZYRTEC ALLERGY) taken for an unspecified indication, start and stop date were not reported.The patient experienced shingles- herpes zoster on 22Apr2021.Therapeutic measures were taken as a result of shingles - herpes zoster.The outcome of the events was not recovered.The patient received Valacyclovir as treatment.The patient had not received any other vaccines within 4 weeks.The patient was not diagnosed with covid prior to vaccination and not tested post vaccination.The patient reported no allergies.  No follow up attempts are needed: No further informations are expected.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Urticaria
Clinical narrative: hives; shingles; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 40 year old adult female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced hives causing urticaria and shingles leading to herpes zoster on an unspecified date with outcome of unknown. The adverse events led to physician office visit. Therapeutic measures were taken as a result of this.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: vesicular rash and redness developed 2 days after covid vaccine.  Being treated for shingles/cutaneous herpes zoster; vesicular rash and redness developed 2 days after covid vaccine.  Being treated for shingles/cutaneous herpes zoster; This is a spontaneous report received from a contactable nurse (patient). A 51-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0153), via intramuscular in left arm on 19Apr2021 at 13:30 (at the age of 51-year-old) as dose 1, single for COVID-19 immunisation at hospital. Medical history included myelodysplastic syndrome from an unknown date and unknown if ongoing, chicken pox from an unknown date and unknown if ongoing (as a child), thrombocytopenia from an unknown date and unknown if ongoing. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN) and multivitamin taken for an unspecified indication, start and stop date were not reported. The patient previously took morphine, demerol apap, vicodin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced vesicular rash and redness developed 2 days after covid vaccine (21Apr2021). being treated for shingles/cutaneous herpes zoster. Device Date was 27Apr2021. The case was reported as non-serious. The adverse events were resulted in emergency room/department or urgent care. Anti-viral, antipruritic, and pain medications were received as treatment for the events. The outcome of the events was reported as resolving.  No follow-up attempts are needed. No further information is expected.  Follow-up attempts are completed. No further information is expected.